Treatment of Breast Pain Using A Medication (Diclofenac) Applied to the Skin
Stopped early · Phase 2/Phase 3 · Has a placebo group
Conditions studied: Breast Pain, Non-cyclical Mastalgia, Surgical Scar-Related Breast Pain
In brief
The study was a randomized, double-blinded, crossover trial of topical diclofenac and placebo (10 weeks of each) for the treatment of noncyclic breast pain.
Key facts
- Study ID
- NCT00276419
- Run by
- Mayo Clinic
- People needed
- 25
- Starts
- 2005-06-01
- Expected to finish
- 2009-05-01
- Last updated by the study team
- 2012-12-20
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: not accepted.
You may qualify if…
- Noncyclic mastalgia or surgical scar-related pain occurring at least 2 days per week and for which the patient desires treatment
- Duration of pain > 2 months (noncyclic mastalgia) or > 4 months (surgical scar-related pain)
- Age > 18 years
- Satisfactory breast examination and directed ultrasound at site of pain (all ages) within 12 months
- Satisfactory mammogram (all women > 30 years of age) within 12 months
- Negative pregnancy test (all women who are premenopausal and have not had hysterectomy or tubal ligation)
You may not qualify if…
- Cyclic mastalgia (as defined above)
- Duration of pain > 2 months (noncyclic mastalgia) or > 4 months (surgical scar-related pain)
- Abnormal breast examination or imaging (abnormality at the site of pain or for which biopsy or surgical consultation is recommended)
- Known pregnancy, lactation, positive pregnancy test, or anticipated pregnancy within 6 months
- Asthma, that has been aggravated by oral nonsteroidal antiinflammatory agents
- Allergy, to diclofenac or any nonsteroidal antiinflammatory agents
- Rash or open lesions at the site on the breast where the topical agent would be applied
- Incomplete or abnormal healing (surgical scar-related pain)
- History of gastrointestinal ulceration, renal dysfunction (creatinine > 1.5), hepatic disease (known liver disease or aspartate aminotransferase (AST) twice normal levels), congestive heart failure and uncontrolled hypertension (blood pressure > 140/90)
Where it is running
- Mayo Clinic — Rochester, Minnesota, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.